TLS Advisors as of Dec. 31, 2022
Portfolio Holdings for TLS Advisors
TLS Advisors holds 21 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| EQT Corporation (EQT) | 25.1 | $5.1M | 151k | 33.83 | |
| Ovid Therapeutics (OVID) | 13.7 | $2.8M | 1.5M | 1.86 | |
| Xoma Corp Del (XOMA) | 11.2 | $2.3M | 124k | 18.40 | |
| Facebook Inc cl a (META) | 8.7 | $1.8M | 15k | 120.36 | |
| Omniab (OABI) | 6.9 | $1.4M | 387k | 3.60 | |
| Silvergate Capital Cl A Ord | 6.8 | $1.4M | 80k | 17.39 | |
| Xenon Pharmaceuticals (XENE) | 6.6 | $1.3M | 34k | 39.43 | |
| Bellus Health | 5.1 | $1.0M | 126k | 8.22 | |
| Tesla Motors (TSLA) | 3.6 | $739k | 6.0k | 123.17 | |
| Mei Pharma | 2.4 | $490k | 2.0M | 0.24 | |
| F-star Therapeutics | 1.7 | $343k | 54k | 6.32 | |
| Yandex Nv-a (YNDX) | 1.7 | $337k | 18k | 18.92 | |
| Hovnanian Enterprises Inc cl a (HOV) | 1.3 | $272k | 6.5k | 42.03 | |
| Ishr Msci Singapore (EWS) | 1.3 | $255k | 14k | 18.75 | |
| Affimed Therapeutics B V | 1.0 | $201k | 162k | 1.24 | |
| Regeneron Pharmaceuticals (REGN) | 0.9 | $180k | 250.00 | 720.00 | |
| Nkarta (NKTX) | 0.8 | $161k | 27k | 6.00 | |
| Range Resources (RRC) | 0.7 | $150k | 60k | 2.51 | |
| Aptose Biosciences | 0.3 | $52k | 89k | 0.58 | |
| Nano Dimension (NNDM) | 0.3 | $51k | 22k | 2.32 | |
| Kludein I Acquisition Corp | 0.0 | $1.0k | 10k | 0.10 |
